- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02631083
The Influence of Glucose Flux on Fat Synthesis in a Whole Body Calorimeter
1. august 2017 oppdatert av: JeyaKumar Henry, Clinical Nutrition Research Centre, Singapore
The Impact of a Low Glycaemic Index (GI) Diet on Daily Blood Glucose Profiles and Energy Flux in Male Chinese Adults.
The study is carried out to find out the inclusion of high and low glycaemic index foods to daily meals and how they impact 24 hour blood glucose fluctuations and energy regulation.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Detaljert beskrivelse
The GI is a method of classifying foods based on the food's ability to raise the blood glucose level.
Low GI foods are recommended as they have a lower impact on blood glucose concentrations.
The research sets out to determine the effect of GI on 24 hour blood glucose profiles and energy regulation in Asians.
Healthy, normal-weight, Chinese males will be recruited.
There will be two sessions (consisting of four days for each session) where they will consume either a high or low GI breakfast, lunch, snack (in the whole body calorimeter), and a high or low glycaemic index dinner at home.
They will take part in two test sessions (each spanning over 3 days) with at least five days in between the two sessions.
Their glycaemic response will be measured using a Continuous Glucose Monitoring System (CGMS) throughout the period, while substrate oxidation will be measured over 10 hours in the calorimeter (from breakfast, lunch and snack).
This study specifically attempts to see how having high and low GI meals impact on blood glucose levels and energy regulation in Asians.
The study is important in that it will be the first of its kind in the whole body calorimeter and enable us to compute the rate of fat synthesis and how it is modulated when subjects are fed a high GI diet (increased glucose excursions) and a low GI diet ( blunted glucose) over 24 hours in healthy Asians.
Obesity and diabetes rates are increasing exponentially in Asian populations and Singapore is no exception.
Devising ways and means to staunch the escalation is therefore a priority.
The findings of the research will contribute towards the long-term objectives of developing Asian specific dietary guidelines for weight and glycaemic control.
The study data will also be important for the provision of practical food-based advocacy for better weight and glycaemic control in Singaporeans.
Studietype
Intervensjonell
Registrering (Faktiske)
15
Fase
- Ikke aktuelt
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
21 år til 40 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Mann
Beskrivelse
Inclusion Criteria:
- Chinese, male
- Age between 21-40 years
- Body mass index between 17 to 25 kg/m2
- Normal blood pressure (<140/80 Hgmm)
- Fasting blood glucose < 6 mmol/L
Exclusion Criteria:
- Having any metabolic diseases (such as diabetes, hypertension etc)
- On prescription medication
- Having glucose 6-phosphate dehydrogenase deficiency (G6PD)
- Partaking in sports at the competitive and/or endurance levels
- Allergic/intolerant to any of the test foods
- Intentionally restricting food intake
- Smoking
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Breakfast, lunch, snack and dinner (high GI)
Subjects will consume meals which are high glycemic index for breakfast (Honey stars cereal), lunch (glutinous rice meal) and snack (white bread and jam) in the whole body calorimeter.
A take-away high glycemic index dinner will be provided.
|
These meals (cereal, rice and bread meals) will be tested in subjects for their glycaemic response (CGMS) and substrate utilization (calorimeter)
|
|
Eksperimentell: Breakfast, lunch, snack and dinner (low GI)
Subjects will consume meals which are low glycemic index for breakfast (All bran cereal), lunch (basmati rice meal) and snack (multigrain bread and sugar-free jam) in the whole body calorimeter.
A take-away low glycemic index dinner will be provided.
|
These meals (cereal, rice and bread meals) will be tested in subjects for their glycaemic response (CGMS) and substrate utilization (calorimeter)
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Daglig blodsukkerprofil
Tidsramme: 24 timer
|
Den daglige totale blodsukkerresponsen måles for hver lav- og høy GI-behandling som området under kurven over 24 timer ved bruk av CGMS til frokost, lunsj, mellommåltid og middag.
|
24 timer
|
|
Glycaemic response The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS)
Tidsramme: 2 hours post consumption
|
The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS) The blood glucose response to low and high GI test foods measured 2 hours post consumption using the Continuous Glucose Monitoring System (CGMS) |
2 hours post consumption
|
|
Substrate oxidation
Tidsramme: 2 hours post consumption
|
The carbohydrate and fat oxidation (i.e Respiratory Quotient) after consumption of low and high GI test foods measured 2 hours post consumption using indirect calorimetry in a whole body calorimeter.
This is done over 10 hours in the whole body calorimeter measured for breakfast, lunch and snack only
|
2 hours post consumption
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
14. november 2014
Primær fullføring (Faktiske)
31. juli 2017
Studiet fullført (Faktiske)
31. juli 2017
Datoer for studieregistrering
Først innsendt
11. desember 2015
Først innsendt som oppfylte QC-kriteriene
11. desember 2015
Først lagt ut (Anslag)
15. desember 2015
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
2. august 2017
Siste oppdatering sendt inn som oppfylte QC-kriteriene
1. august 2017
Sist bekreftet
1. august 2017
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2014/00960
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
IPD-planbeskrivelse
No plan to share data
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .